Could a simple mineral improve lung cancer treatment?

NCT ID NCT07149649

First seen Jun 25, 2026 · Last updated Jul 17, 2026 · Updated 3 times

Summary

This study tests whether adding magnesium to standard chemo-immunotherapy helps people with advanced non-small cell lung cancer. About 230 participants will receive either magnesium or a placebo, as both tablets and infusions. Neither patients nor doctors know who gets what. The goal is to see if magnesium improves survival and is well tolerated.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
magnesium (as Magnesiocard tablets and Magnesium Diasporal IV)
What this could lead to
If it works, this could show that adding magnesium helps standard treatment work better and longer for advanced lung cancer.
What could go wrong
This is an early-to-mid stage trial with only 230 participants. Magnesium may not improve outcomes, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC NSCLC - NON-SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Kantonsspital - St. Gallen

    RECRUITING

    Sankt Gallen, CH-9007, Switzerland

  • Kantonsspital Aarau

    RECRUITING

    Aarau, CH-5001, Switzerland

  • Kantonsspital Baden

    RECRUITING

    Baden, 5404, Switzerland

  • Kantonsspital Graubuenden

    RECRUITING

    Chur, CH-7000, Switzerland

  • Kantonsspital Olten

    RECRUITING

    Olten, 4600, Switzerland

  • Kantonsspital Winterthur

    RECRUITING

    Winterthur, 8401, Switzerland

  • Luzerner Kantonsspital

    RECRUITING

    Lucerne, 6000, Switzerland

  • Spital STS AG

    RECRUITING

    Thun, 3600, Switzerland

  • St. Claraspital

    RECRUITING

    Basel, 4058, Switzerland

  • Tumorzentrum Aarau - Hirslanden TZA

    RECRUITING

    Aarau, 5001, Switzerland

  • Universitätsspital Basel

    RECRUITING

    Basel, 4058, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.